Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Blood|April 28, 2006
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Nicola Goekbuget, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITDAnthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.Critical Reviews in Oncology/Hematology|October 26, 2005
Treatment of older patients with AMLThomas Büchner, Wolfgang E Berdel, Bernhard Wörmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2013
Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysisMatthias Stelljes, Utz Krug, Dietrich W Beelen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studiesTorsten Haferlach, Claudia Schoch, Helmut Löffler, et al.Blood|November 1, 2014
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trialDieter Hoelzer, Jan Walewski, Hartmut Döhner, et al.Blood|January 10, 2009
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCGJan Braess, Karsten Spiekermann, Peter Staib, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trialHubert Serve, Utz Krug, Ruth Wagner, et al.Leukemia|May 14, 2024
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocolsMartin Neumann, Thomas Beder, Lorenz Bastian, et al.Haematologica|September 24, 2016
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trialChristian Straka, Peter Liebisch, Hans Salwender, et al.Pageof 8